Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Toulemonde

Showing results (61-70 of 67) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 67 results.
Presse Medicale (Paris, France : 1983)|May 23, 1987
[Comparative study of heparin and a very low molecular-weight heparin in hemodialysis in chronic renal insufficiency]B Hory, A Cachoux, F Saunier, et al.
Journal Des Maladies Vasculaires|January 1, 1987
[Use of a low molecular weight heparin, CY 222, in the treatment of consumption coagulopathy]G Audibert, H Lambert, F Toulemonde, et al.
Therapie|March 1, 1984
[Oral administration of heparin and low molecular weight heparin fractions in rabbits]C Doutremepuich, F Toulemonde, M C Kuttler, et al.
Presse Medicale (Paris, France : 1983)|February 13, 1988
[A new treatment of deep venous thrombosis: low molecular weight heparin fractions. Randomized study]R Faivre, Y Neuhart, Y Kieffer, et al.
Journal Des Maladies Vasculaires|January 1, 1987
[CY 222, a very low molecular weight heparin, in the curative treatment of deep venous thrombosis. Apropos of 95 cases. Clinical and phlebographic results]G Janvier, G Dugrais, S Winnock, et al.
La Revue De Medecine Interne|January 1, 1990
[Prevention of deep venous thrombosis of the leg by a very low molecular weight heparin fraction (CY 222) in patients with hemiplegia following cerebral infarction: a randomized pilot study (30 patients)]A Elias, L Milandre, G Lagrange, et al.
Scientific Reports|September 27, 2024
Seed morphometrics unravels the evolutionary history of grapevine in FranceL Bouby, V Bonhomme, S Ivorra, et al.
Pageof 7

Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
Presse Medicale (Paris, France : 1983)|May 23, 1987
[Comparative study of heparin and a very low molecular-weight heparin in hemodialysis in chronic renal insufficiency]B Hory, A Cachoux, F Saunier, et al.
Journal Des Maladies Vasculaires|January 1, 1987
[Use of a low molecular weight heparin, CY 222, in the treatment of consumption coagulopathy]G Audibert, H Lambert, F Toulemonde, et al.
Therapie|March 1, 1984
[Oral administration of heparin and low molecular weight heparin fractions in rabbits]C Doutremepuich, F Toulemonde, M C Kuttler, et al.
Presse Medicale (Paris, France : 1983)|February 13, 1988
[A new treatment of deep venous thrombosis: low molecular weight heparin fractions. Randomized study]R Faivre, Y Neuhart, Y Kieffer, et al.
Journal Des Maladies Vasculaires|January 1, 1987
[CY 222, a very low molecular weight heparin, in the curative treatment of deep venous thrombosis. Apropos of 95 cases. Clinical and phlebographic results]G Janvier, G Dugrais, S Winnock, et al.
La Revue De Medecine Interne|January 1, 1990
[Prevention of deep venous thrombosis of the leg by a very low molecular weight heparin fraction (CY 222) in patients with hemiplegia following cerebral infarction: a randomized pilot study (30 patients)]A Elias, L Milandre, G Lagrange, et al.
Scientific Reports|September 27, 2024
Seed morphometrics unravels the evolutionary history of grapevine in FranceL Bouby, V Bonhomme, S Ivorra, et al.
Pageof 7